• Ardent Health's board determined on October 19, 2026, that former CEO Martin J. Bonick's departure warranted termination for cause.
• The determination reflected Bonick's failure to fully disclose third-party compensation required under company policies.
• His separation was reclassified as termination for cause effective June 2, 2026.
• Remaining severance payments and benefits will stop, including approximately $4.5 million in unpaid cash severance.
• All outstanding unvested performance-based restricted stock units (PRSUs) will be canceled or forfeited.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ardent Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-118499), on October 23, 2026, and is solely responsible for the information contained therein.